Ekso Non Operating Income Net Other vs Total Operating Expenses Analysis
EKSO Stock | USD 1.36 0.09 6.21% |
Ekso Bionics financial indicator trend analysis is much more than just examining Ekso Bionics Holdings latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ekso Bionics Holdings is a good investment. Please check the relationship between Ekso Bionics Non Operating Income Net Other and its Total Operating Expenses accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
Non Operating Income Net Other vs Total Operating Expenses
Non Operating Income Net Other vs Total Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ekso Bionics Holdings Non Operating Income Net Other account and Total Operating Expenses. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Ekso Bionics' Non Operating Income Net Other and Total Operating Expenses is -0.27. Overlapping area represents the amount of variation of Non Operating Income Net Other that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of Ekso Bionics Holdings, assuming nothing else is changed. The correlation between historical values of Ekso Bionics' Non Operating Income Net Other and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Operating Income Net Other of Ekso Bionics Holdings are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Non Operating Income Net Other i.e., Ekso Bionics' Non Operating Income Net Other and Total Operating Expenses go up and down completely randomly.
Correlation Coefficient | -0.27 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Non Operating Income Net Other
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most indicators from Ekso Bionics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ekso Bionics Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. As of the 19th of May 2024, Sales General And Administrative To Revenue is likely to grow to 1.01, while Selling General Administrative is likely to drop about 8.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 6.7M | 6.2M | 9.7M | 5.1M | Total Revenue | 11.2M | 12.9M | 18.3M | 12.3M |
Ekso Bionics fundamental ratios Correlations
Click cells to compare fundamentals
Ekso Bionics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ekso Bionics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 21.9M | 20.6M | 49.2M | 40.9M | 28.9M | 26.0M | |
Short Long Term Debt Total | 3.9M | 3.9M | 2.2M | 7.5M | 7.2M | 3.7M | |
Other Current Liab | 1.7M | 1.4M | 2.3M | 2.3M | 2.7M | 2.3M | |
Total Current Liabilities | 7.8M | 5.0M | 6.9M | 9.2M | 8.1M | 6.6M | |
Total Stockholder Equity | 6.8M | 4.4M | 37.2M | 25.4M | 12.6M | 13.6M | |
Net Debt | (7M) | (9.0M) | (38.2M) | (13.0M) | (1.5M) | (1.5M) | |
Retained Earnings | (183.3M) | (199.1M) | (208.9M) | (223.9M) | (239.1M) | (227.2M) | |
Cash | 10.9M | 12.9M | 40.4M | 20.5M | 8.6M | 16.1M | |
Cash And Short Term Investments | 10.9M | 12.9M | 40.4M | 20.5M | 8.6M | 8.2M | |
Common Stock Total Equity | 60K | 63K | 87K | 8K | 9.2K | 8.7K | |
Liabilities And Stockholders Equity | 21.9M | 20.6M | 49.2M | 40.9M | 28.9M | 26.0M | |
Non Current Liabilities Total | 7.3M | 11.2M | 5.1M | 6.3M | 8.2M | 7.4M | |
Total Liab | 15.1M | 16.2M | 11.9M | 15.5M | 16.3M | 13.4M | |
Total Current Assets | 18.8M | 18.4M | 47.8M | 31.0M | 20.2M | 22.1M | |
Short Term Debt | 2.8M | 548K | 229K | 2.7M | 1.6M | 1.1M | |
Common Stock | 63K | 87K | 8K | 13K | 15K | 14.3K | |
Common Stock Shares Outstanding | 4.8M | 7.2M | 12.3M | 13.0M | 13.9M | 14.6M | |
Other Stockholder Equity | 189.9M | 204.4M | 246.1M | 248.8M | 251.6M | 179.6M | |
Other Liab | 6.2M | 7.9M | 3.1M | 1.4M | 1.3M | 1.2M | |
Net Tangible Assets | 6.6M | 4.4M | 37.2M | 19.8M | 22.8M | 15.5M | |
Property Plant And Equipment Net | 2.7M | 1.9M | 1.2M | 4.0M | 3.0M | 2.7M | |
Current Deferred Revenue | 1.5M | 1.5M | 1.2M | 1.1M | 2.0M | 1.4M | |
Accounts Payable | 1.9M | 1.5M | 3.1M | 3.2M | 1.8M | 2.5M | |
Non Current Assets Total | 3.1M | 2.2M | 1.4M | 9.9M | 8.7M | 5.0M | |
Non Currrent Assets Other | 178K | 320K | 164K | 231K | 392K | 504.2K | |
Other Assets | 134K | 178K | 1.0M | 164K | 147.6K | 140.2K | |
Long Term Debt | 407K | 9.1M | 2.0M | 3.8M | 4.8M | 3.8M | |
Net Receivables | 5.2M | 3.4M | 4.7M | 4.6M | 5.6M | 3.9M | |
Long Term Debt Total | 4.8M | 2.6M | 407K | 9.1M | 10.5M | 11.0M | |
Capital Surpluse | 165.8M | 173.9M | 189.9M | 204.4M | 235.0M | 165.0M | |
Inventory | 2.5M | 2.0M | 2.2M | 5.2M | 5.1M | 2.9M | |
Other Current Assets | 238K | 191K | 485K | 700K | 875K | 597.9K | |
Property Plant And Equipment Gross | 2.7M | 1.9M | 1.2M | 4.0M | 6.2M | 6.5M | |
Accumulated Other Comprehensive Income | 50K | (847K) | (17K) | 563K | 156K | 163.8K | |
Property Plant Equipment | 2.7M | 1.2M | 1.2M | 4.0M | 4.6M | 2.6M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Ekso Stock analysis
When running Ekso Bionics' price analysis, check to measure Ekso Bionics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ekso Bionics is operating at the current time. Most of Ekso Bionics' value examination focuses on studying past and present price action to predict the probability of Ekso Bionics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ekso Bionics' price. Additionally, you may evaluate how the addition of Ekso Bionics to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Ekso Bionics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.97) | Revenue Per Share 1.202 | Quarterly Revenue Growth (0.09) | Return On Assets (0.26) | Return On Equity (0.81) |
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.